Research programme: antimalarial compounds - Biomes
Alternative Names: Anti-malarials research programme - Biomes; Antimalarial compounds research programme - Biomes; Research programme: anti-malarials - Biomes; S-triazinesLatest Information Update: 16 Mar 2007
At a glance
- Originator Biomes Pharmaceuticals
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 20 Jul 2000 New profile
- 20 Jul 2000 This research is available for licensing (http://www.btgplc.com)
- 20 Jul 2000 Preclinical development for Malaria treatment in USA (Unknown route)